Skip Nav Destination
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site
Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia
Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study: Presented at the 43rd annual American Society of Hematology meeting, Orlando, Florida, December 2001.
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia: Presented in part at the 10th International Symposium on Viral Hepatitis and Liver Disease, April 2000, Atlanta, GA; abstract no. C077.
Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia
Issue Archive
March 15 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
PERSPECTIVE
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
Clinical Trials & Observations
Nichola Cooper,B. Michael R. Woloski,Erin M. Fodero,Maria Novoa,Melissa Leber,Juerg H. Beer,James B. Bussel
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
Clinical Trials & Observations
Moshe Talpaz,Richard T. Silver,Brian J. Druker,John M. Goldman,Carlo Gambacorti-Passerini,Francois Guilhot,Charles A. Schiffer,Thomas Fischer,Michael W. N. Deininger,Anne L. Lennard,Andreas Hochhaus,Oliver G. Ottmann,Alois Gratwohl,Michele Baccarani,Richard Stone,Sante Tura,Francois-Xavier Mahon,Sofia Fernandes-Reese,Insa Gathmann,Renaud Capdeville,Hagop M. Kantarjian,Charles L. Sawyers
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program
Clinical Trials & Observations
Hugo Castro-Malaspina,Richard E. Harris,James Gajewski,Norma Ramsay,Robert Collins,Bernie Dharan,Roberta King,H. Joachim Deeg
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia
Clinical Trials & Observations
Michael N. Dworzak,Gertraud Fröschl,Dieter Printz,Georg Mann,Ulrike Pötschger,Nora Mühlegger,Gerhard Fritsch,Helmut Gadner,for the Austrian Berlin-Frankfurt-Münster Study Group
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation
Clinical Trials & Observations
Daniel J. Weisdorf,Claudio Anasetti,Joseph H. Antin,Nancy A. Kernan,Craig Kollman,David Snyder,Effie Petersdorf,Gene Nelson,Philip McGlave
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
Clinical Trials & Observations
Christian Junghanss,Michael Boeckh,Rachel A. Carter,Brenda M. Sandmaier,Michael B. Maris,David G. Maloney,Thomas Chauncey,Peter A. McSweeney,Marie-Térèse Little,Lawrence Corey,Rainer Storb
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
Clinical Trials & Observations
Vassilios I. Avramis,Susan Sencer,Antonia P. Periclou,Harland Sather,Bruce C. Bostrom,Lewis J. Cohen,Alice G. Ettinger,Lawrence J. Ettinger,Janet Franklin,Paul S. Gaynon,Joanne M. Hilden,Beverly Lange,Fataneh Majlessipour,Pracad Mathew,Michael Needle,Joseph Neglia,Gregory Reaman,John S. Holcenberg
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
Clinical Trials & Observations
Ann E. Woolfrey,Claudio Anasetti,Barry Storer,Kristine Doney,Laurie A. Milner,Eric L. Sievers,Paul Carpenter,Paul Martin,Effie Petersdorf,Frederick R. Appelbaum,John A. Hansen,Jean E. Sanders
GENE THERAPY
HEMATOPOIESIS
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells
Ulrich Steidl,Ralf Kronenwett,Ulrich-Peter Rohr,Roland Fenk,Slawomir Kliszewski,Christian Maercker,Peter Neubert,Manuel Aivado,Judith Koch,Olga Modlich,Hans Bojar,Norbert Gattermann,Rainer Haas
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice
Kazuya Shimoda,Hiroko Tsutsui,Kenichi Aoki,Kouji Kato,Tadashi Matsuda,Akihiko Numata,Ken Takase,Tetsuya Yamamoto,Hideyuki Nukina,Tomoaki Hoshino,Yoshinobu Asano,Hisashi Gondo,Takashi Okamura,Seiichi Okamura,Kei-Ichi Nakayama,Kenji Nakanishi,Yoshiyuki Niho,Mine Harada
NEOPLASIA
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
Hervé Avet-Loiseau,Thierry Facon,Bernard Grosbois,Florence Magrangeas,Marie-José Rapp,Jean-Luc Harousseau,Stéphane Minvielle,Régis Bataille,for the Intergroupe Francophone du Myélome
PHAGOCYTES
TRANSPLANTATION
BRIEF REPORTS
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site
Brief Report
Lucio Tentori,Carlo Leonetti,Marco Scarsella,Giulia d'Amati,Ilaria Portarena,Gabriella Zupi,Enzo Bonmassar,Grazia Graziani
Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia
Clinical Trials & Observations
Brief Report
Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study: Presented at the 43rd annual American Society of Hematology meeting, Orlando, Florida, December 2001.
Clinical Trials & Observations
Brief Report
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
Clinical Trials & Observations
Brief Report
Steven M. Devine,Ron Hoffman,Amit Verma,Rajul Shah,Basil A. Bradlow,Wendy Stock,Vera Maynard,Ellen Jessop,David Peace,Marianne Huml,Deana Thomason,Yi-Hsiang Chen,Koen van Besien
Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia: Presented in part at the 10th International Symposium on Viral Hepatitis and Liver Disease, April 2000, Atlanta, GA; abstract no. C077.
Clinical Trials & Observations
Brief Report
Milvia Casato,Cristina Mecucci,Vincent Agnello,Massimo Fiorilli,Glenn B. Knight,Caterina Matteucci,Lei Gao,Jonathan Kay
Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia
Clinical Trials & Observations
Brief Report
Gerard Tobin,Ulf Thunberg,Anna Johnson,Ingrid Thörn,Ola Söderberg,Magnus Hultdin,Johan Botling,Gunilla Enblad,Jan Sällström,Christer Sundström,Göran Roos,Richard Rosenquist
CORRESPONDENCE
Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia
Alistair G. Reid,Brian J. P. Huntly,Eveline Hennig,Dietger Niederwieser,Lynda J. Campbell,Nick Bown,Nick Telford,Helen Walker,Colin D. Grace,Michael W. Deininger,Anthony R. Green,Elisabeth P. Nacheva
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals